Deutsche Bank’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Deutsche Bank’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,074	Closed	-$117K	–	4489
2020 Q2	$117K	Buy	+1,074	New	+$188K	﹤0.01%	3371
2019 Q1	–	Sell	-37	Closed	-$59K	–	5518
2018 Q4	$59K	Buy	37 +34	+1,133%	+$80.6K	﹤0.01%	4423
2018 Q3	$8K	Buy	+3	New	+$8.67K	﹤0.01%	5129
2015 Q4	–	Hold	0	–	-$5K	–	5467
2015 Q3	–	Hold	0	–	–	–	5052

Other funds holding TMBR

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Deutsche Bank's TMBR Position: Q3 2020 in Review

Deutsche Bank sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q3 2020, closing a stake of 1,074 shares — an estimated $117K sold.

Deutsche Bank first reported a position in TMBR in Q3 2018 and held it in 3 quarters. The position peaked at $117K in Q2 2020. 6 funds tracked by Wall St. Rank hold TMBR as of Q3 2020.

Deutsche Bank reported no remaining Timber Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Deutsche Bank sold 1,074 Timber Pharmaceuticals, Inc. shares in Q3 2020, an estimated $117K.
Deutsche Bank first reported a position in Timber Pharmaceuticals, Inc. in Q3 2018 and held it in 3 quarters.
Deutsche Bank's Timber Pharmaceuticals, Inc. position peaked at $117K in Q2 2020.
6 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q3 2020.

Based on Deutsche Bank's 13F filing for Q3 2020, filed 12 Nov 2020.